Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly R, Raad I. Comparative analysis of vancomycin resistant Enterococcus faecalis vs. VRE faecium in cancer patients. Abstract # 443. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada.

/in /by

Torres HA, Aguilera E, Rohatgi N, Raad II, Sepulveda C, Safdar A, Knotoyiannis DP, Chemaly RF. Cytomegalovirus pneumonia in patients with hematologic malignancies: an autopsy-based case-control study. Abstract # 787. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada.

/in /by

Chemaly RF, Hachem R, Hanmod S, Adachi J, Kontoyiannis D, Safdar A, Raad II, Rolston KVI. Clinical experience with tigecycline in cancer patients: a report on 28 cases. Abstract # 1719. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada.

/in /by

Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II. Scedosporium in a tertiary care cancer center in the past 16 years. Abstract # 554. The 44th Annual Meeting of the Infectious Diseases Society of America. October 12–15, 2006, Toronto, Ontario, Canada.

/in /by

Safdar A*, Rodriguez G, Balakrishnan M, Tarrand J, Rolston KVI. Changing trends of bacteremia in patients with cancer. Analysis of 2,080 quantitative blood cultures during 1998 and 2004. Abstract # 94. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland.

/in /by

Safdar A*, Rodriguez G, Rolston KVI, Kantarjian HM, Bodey GP, Champlin RE, Knotoyiannis D, Raad II. Efficacy of high-dose (100mg) caspofungin combination antifungal therapy in cancer patients with invasive fungal infections: case-controlled observational analysis during 2002-2004. Abstract # 93. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland.

/in /by

Safdar A*, Rodriguez A, Luis FE, Romaguera JE, Hagemeister FB, McLauglin PW, Kwak L, Couch RB. A trial of increasing dose of baculovirus-expressed trivalent influenza HA vaccine: prospective, randomized, double blind study in adult patients with B-cell non-Hodgkin’s lymphoma. Abstract # 92. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland.

/in /by

Safdar A*, Rodriguez G, Lichtiger B, Champlin R, Rreireich EJ, Kantarjian HM. Safety and efficacy of recombinant interferon-gamma-1b immune adjuvant in 20 patients receiving high-dose donor granulocyte transfusions–an observational study during 2000 – 2004. Abstract # 91. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland.

/in /by

Safdar A*, Rodriguez G, Delima M, et al. Infections complicating unrelated donor cordblood stem-cell transplantation: 281 episodes in recipients of 100 CBST at a comprehensive cancer center (1996-2005). Abstract # 42. The 14th International Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. July 2–5, 2006, Crans-Montana, Switzerland.

/in /by

Safdar A*, Couch RB. Randomized-controlled, double-blinded baculovirus-expressed trivalent influenza HA vaccine trial in adult patients with non-Hodgkin’s lymphoma 2004. Abstract # 05-A-19-NFID. The 9th Annual Conference on Vaccine Research. National Foundation for Infectious Diseases. May 8 – 10, 2006, Baltimore, MD. ORAL PRESENTATION

/in /by